Allogene Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Allogene Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ALLO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001737287
Board of directors
-
Arie Belldegrun · DirectorSince 2023
-
David D. Chang · Director · President and CEOSince 2023
-
Deborah M. Messemer · DirectorSince 2023
-
Elizabeth A. Barrett · DirectorSince 2023
-
Franz B. Humer · DirectorSince 2023
-
Joshua A. Kazam · DirectorSince 2023
-
Owen N. Witte · DirectorSince 2023
-
Stephen Mayo · DirectorSince 2023
-
Vicki L. Sato · DirectorSince 2023
Chief executives
David D. Chang
· President and CEO
Dates unknown
Board connections
4 of this board's directors also sit on 8 other boards.
- via Vicki L. Sato
- via Arie Belldegrun
- via Stephen Mayo
- via Deborah M. Messemer
- via Stephen Mayo
- via Deborah M. Messemer
- via Arie Belldegrun
- via Vicki L. Sato
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 18, 2023 | Deborah M. Messemer Director | Open-market sale | −18,640 | $2.70 | $50,328 |
| Oct 16, 2023 | Geoffrey M. Parker Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +400,000 | — | — |
| Oct 16, 2023 | Geoffrey M. Parker Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +390,000 | — | — |
| Aug 14, 2023 | Douglas Earl Martin Officer (GENERAL COUNSEL) | Grant or award | +108,958 | — | — |
| Aug 14, 2023 | Douglas Earl Martin Officer (GENERAL COUNSEL) | Grant or award | +326,876 | — | — |
| Aug 10, 2023 | CHEN YINLIN JACK Officer (SVP, Finance) | Grant or award | +11,401 | — | — |
| Aug 7, 2023 | Stephen Mayo Director | Open-market sale | −10,000 | $4.29 | $42,900 |
| Jun 13, 2023 | Deborah M. Messemer Director | Grant or award | +74,561 | — | — |
| Jun 13, 2023 | Vicki L. Sato Director | Grant or award | +59,649 | — | — |
| Jun 13, 2023 | Franz B. Humer Director | Grant or award | +74,561 | — | — |
| Jun 13, 2023 | Owen N. Witte Director | Grant or award | +74,561 | — | — |
| Apr 24, 2023 | Timothy L. Moore Officer (Chief Technical Officer) | Grant or award | +186,219 | — | — |
| Apr 1, 2023 | Smith Lillian Officer (VP, Corporate Counsel) | Grant or award | +56,545 | — | — |
| Mar 22, 2023 | MOORE ALISON Officer (Chief Technical Officer) | Grant or award | +558,094 | — | — |
| Mar 22, 2023 | SCHMIDT ERIC THOMAS Officer (Chief Financial Officer) | Grant or award | +558,094 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.